Albert F. Hummel is Director at WATSON PHARMACEUTICALS INC (WPI). They have made 8 open-market trades across 2 companies since 2010, most recently 2017-09-16.
CIK 0001236489
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACT | SELL | 2013-09-16 | 2013-09-18 | $137.81 | $854K | +0.0% | +0.0% | +0.0% |
| ACT | SELL | 2013-08-22 | 2013-08-26 | $134.44 | $5.4M | +0.0% | +0.0% | +0.0% |
| ACT | SELL | 2013-08-13 | 2013-08-15 | $133.85 | $1.3M | +0.0% | +0.0% | +0.0% |
| WPI | SELL | 2012-05-29 | 2012-05-29 | $73.74 | $1.4M | N/A | N/A | N/A |
| WPI | SELL | 2012-05-02 | 2012-05-04 | $74.73 | $798K | N/A | N/A | N/A |
| WPI | SELL | 2011-09-16 | 2011-09-16 | $67.25 | $673K | N/A | N/A | N/A |
| WPI | SELL | 2011-05-06 | 2011-05-09 | $63.36 | $950K | N/A | N/A | N/A |
| WPI | SELL | 2010-08-24 | 2010-08-25 | $42.07 | $841K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.